Literature DB >> 2359428

Increased need for thyroxine during pregnancy in women with primary hypothyroidism.

S J Mandel1, P R Larsen, E W Seely, G A Brent.   

Abstract

BACKGROUND AND METHODS: Women with hypothyroidism have been thought not to require an increase in thyroxine replacement during pregnancy. To evaluate the effects of pregnancy on thyroxine requirements, we retrospectively reviewed the thyroid function of 12 women receiving treatment for primary hypothyroidism before, during, and after pregnancy.
RESULTS: In all patients, the serum thyrotropin level increased during pregnancy. The mean (+/- SE) serum free-thyroxine index decreased from 111.0 +/- 5.8 before pregnancy to 86.5 +/- 5.2 during pregnancy (normal, 64 to 142; P less than 0.05), and the mean serum thyrotropin level increased from 2.0 +/- 0.5 mU per liter before pregnancy to 13.5 +/- 3.3 mU per liter during pregnancy (normal, 0.5 to 5.0 mU per liter; P less than 0.01). Because of high thyrotropin levels, the thyroxine dose was increased in 9 of the 12 patients. Among the three patients who did not require an increased thyroxine dose were two with low serum thyrotropin levels before pregnancy, suggesting excessive replacement at that time. The mean thyroxine dose before pregnancy was 0.102 +/- 0.009 mg per day; it was increased to 0.148 +/- 0.015 mg per day during pregnancy (P less than 0.01). The mean postpartum serum free-thyroxine index was 136.6 +/- 11.4 (P less than 0.05 as compared with values before and during pregnancy), and the mean postpartum serum thyrotropin level was 1.4 +/- 0.4 mU per liter (P less than 0.01 as compared with levels during pregnancy), demonstrating a decrease in the thyroxine requirement. The mean postpartum thyroxine dose was decreased to 0.117 +/- 0.011 mg per day (P less than 0.01 as compared with the dose during pregnancy).
CONCLUSIONS: Our results indicate that the need for thyroxine increases in many women with primary hypothyroidism when they are pregnant, as reflected by an increase in serum thyrotropin concentrations. Although the effects of this modest level of hypothyroidism are not known, we think it prudent to monitor thyroid function throughout gestation and after delivery and to adjust the thyroxine dose to maintain a normal serum thyrotropin level.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2359428     DOI: 10.1056/NEJM199007123230204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  37 in total

1.  Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization.

Authors:  Clarisa R Gracia; Christopher B Morse; Grace Chan; Samantha Schilling; Maureen Prewitt; Mary D Sammel; Susan J Mandel
Journal:  Fertil Steril       Date:  2012-01-18       Impact factor: 7.329

2.  Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism.

Authors:  M Gola; M Doga; G Mazziotti; S Bonadonna; A Giustina
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

Review 3.  [Thyroid and pregnancy].

Authors:  Johanna Mayr; Susanne Kohlfürst; Hans-Jürgen Gallowitsch; Peter Lind; Peter Mikosch
Journal:  Wien Med Wochenschr       Date:  2010-04

4.  Thyroid function: the complexity of maternal hypothyroidism during pregnancy.

Authors:  Erik K Alexander
Journal:  Nat Rev Endocrinol       Date:  2009-09       Impact factor: 43.330

5.  Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum.

Authors:  Alex Stagnaro-Green; Marcos Abalovich; Erik Alexander; Fereidoun Azizi; Jorge Mestman; Roberto Negro; Angelita Nixon; Elizabeth N Pearce; Offie P Soldin; Scott Sullivan; Wilmar Wiersinga
Journal:  Thyroid       Date:  2011-07-25       Impact factor: 6.568

6.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

7.  Maternal hypothyroidism and subsequent neuropsychological outcome of the progeny: a family portrait.

Authors:  Daniela Pasquali; Marco Carotenuto; Paola Leporati; Maria Esposito; Lorenzo Antinolfi; Daniela Esposito; Giacomo Accardo; Carlo Carella; Luca Chiovato; Mario Rotondi
Journal:  Endocrine       Date:  2015-03-06       Impact factor: 3.633

8.  Pharmacotherapy and pregnancy: highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy.

Authors:  David M Haas; Mary F Hebert; Offie P Soldin; David A Flockhart; Parvaz Madadi; James J Nocon; Christina D Chambers; Gary D Hankins; Shannon Clark; Katherine L Wisner; Lang Li; Jamie L Renbarger; Lee A Learman
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

Review 9.  Autoimmune thyroid disease in pregnancy: a review.

Authors:  Juan C Galofre; Terry F Davies
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

Review 10.  Treatment of hyper- and hypothyroidism in pregnancy.

Authors:  J H Lazarus
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.